Primary Systemic Amyloidosis — Trials

Primary Systemic Amyloidosis — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–16 of 16 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03499808	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis	completed	Phase 2	43	SWOG Cancer Research NetworkNETWORK	1	Sep 9, 2025	clinicaltrials
NCT00520767	Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease	completed	Phase 2	35	Barbara Ann Karmanos Cancer InstituteOTHER	1	Dec 22, 2023	clinicaltrials
NCT00224393	Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis	completed	Phase 2	60	The Cleveland ClinicOTHER	0	May 30, 2023	clinicaltrials
NCT01849783	Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma

Data updated 22 days agoSource updated Sep 9, 2025source: clinicaltrials